CD4 and T-cell acute lymphoblastic leukemia: Recently, Canakci et al. used an anti-CD4 conjugated polymer nanoparticle that selectively targeted a cytotoxic drug molecule to the primary CD4+ T cells or CD4 lymphoma cells in a T cell ALL mouse model.